Protease inhibitor drugs

Protease inhibitor, class of antiretroviral drugs used to treat HIV retrovirus infection in AIDS patients. Protease inhibitors are

Protease inhibitors. Protease inhibitors (PIs) impede another enzyme called HIV protease. HIV also requires protease to replicate. Entry inhibitors. As the name suggests, these drugs prevent

by MW Abiyyi Cited by 1COVID-19: Drug Repurposing of Serine Protease Inhibitor Against TMPRSS2, Indonesian Journal of serine protease inhibitors exert

The HIV drugs that are being studied to treat COVID-19 are mostly in a class of drugs called protease inhibitors. Protease inhibitors block (inhibit) a viral enzyme called protease.

also referred to as 3CLpro or nsp5 protease) inhibitor, and ritonavir, an HIV-1 protease inhibitor and. CYP3A inhibitor, is indicated for the treatment of

Protease inhibitors. Omeprazole has been reported to interact with some protease inhibitors. Therapeutic drug monitoring of digoxin should then be

The experimental protease inhibitor drugs Zmapp and Brincidofovir are currently being tested to treat the ebola virus disease. Protease

Another important antiviral drugs classification is protease inhibitors. This type of antiviral drug acts on the protease enzyme of the HIV viruses and distorts

Protease inhibitors are drugs that treat HIV by blocking enzymes (proteases) from helping HIV replicate. Protease inhibitors were among the first drugs to help successfully control HIV in